Clinical trials & evidence

Cardio-oncology demand is rising, but training gaps are holding systems back

Cholesterol prevention is moving earlier. Is Europe ready to treat inherited risk before adulthood?

Gastric Cancer Gets a New Biomarker Access Signal

CIDP Treatment Moves Beyond the IVIg Default

mRNA Flu Shots Are No Longer a Pandemic Experiment

MRD Testing Moves From Prognosis Toward Treatment Action

Narcolepsy Treatment Starts Targeting the Cause

Optic Neuritis Moves Into the Neuroprotection Race

Huntington’s Gene Therapy Moves Back Toward the FDA Door
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
